BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2873440)

  • 1. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man.
    Cuss FM; Dixon CM; Barnes PJ
    Lancet; 1986 Jul; 2(8500):189-92. PubMed ID: 2873440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of inhaled aerosol of platelet activating factor on pulmonary function and airway responsiveness in normal subjects].
    Li Q
    Zhonghua Jie He He Hu Xi Za Zhi; 1992 Aug; 15(4):222-4, 255. PubMed ID: 1307517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled PAF fails to induce airway hyperresponsiveness to methacholine in normal human subjects.
    Lai CK; Jenkins JR; Polosa R; Holgate ST
    J Appl Physiol (1985); 1990 Mar; 68(3):919-26. PubMed ID: 2187854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The actions of GR32191B, a thromboxane receptor antagonist, on the effects of inhaled PAF on human airways.
    Stenton SC; Ward C; Duddridge M; Harris A; Palmer JB; Hendrick DJ; Walters EH
    Clin Exp Allergy; 1990 May; 20(3):311-7. PubMed ID: 2142013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of salbutamol on bronchoconstriction, bronchial hyperresponsiveness, and leucocyte responses induced by platelet activating factor in man.
    Chung KF; Dent G; Barnes PJ
    Thorax; 1989 Feb; 44(2):102-7. PubMed ID: 2648645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketotifen inhibits the cutaneous but not the airway responses to platelet-activating factor in man.
    Chung KF; Minette P; McCusker M; Barnes PJ
    J Allergy Clin Immunol; 1988 Jun; 81(6):1192-8. PubMed ID: 3288683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of inhaled PAF in humans on circulating and bronchoalveolar lavage fluid neutrophils. Relationship to bronchoconstriction and changes in airway responsiveness.
    Wardlaw AJ; Chung KF; Moqbel R; MacDonald AJ; Hartnell A; McCusker M; Collins JV; Barnes PJ; Kay AB
    Am Rev Respir Dis; 1990 Feb; 141(2):386-92. PubMed ID: 2405759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activating factor does not cause a reproducible increase in bronchial responsiveness in normal man.
    Spencer DA; Green SE; Evans JM; Piper PJ; Costello JF
    Clin Exp Allergy; 1990 Sep; 20(5):525-32. PubMed ID: 2253083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bronchoconstrictor properties of platelet-activating factor in humans.
    Rubin AH; Smith LJ; Patterson R
    Am Rev Respir Dis; 1987 Nov; 136(5):1145-51. PubMed ID: 3314611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAF-induced bronchial hyperresponsiveness in the rabbit: contribution of platelets and airway smooth muscle.
    Coyle AJ; Spina D; Page CP
    Br J Pharmacol; 1990 Sep; 101(1):31-8. PubMed ID: 2282464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled platelet-activating factor increases airway sensitivity but not maximal airway narrowing to methacholine in normal subjects.
    Bellofiore S; Ciancio N; Pennisi A; Coco G; Passanisi G; Ricciardolo FL; Novo S; Di Maria GU
    Monaldi Arch Chest Dis; 1994 Sep; 49(4):288-92. PubMed ID: 8000412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a PAF antagonist, BN52063, on PAF-induced bronchoconstriction in normal subjects.
    Roberts NM; McCusker M; Chung KF; Barnes PJ
    Br J Clin Pharmacol; 1988 Jul; 26(1):65-72. PubMed ID: 3203062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of theophylline on airway responses to inhaled platelet-activating factor in man.
    Chung KF; Lammers JW; McCusker M; Roberts NM; Nichol GM; Barnes PJ
    Eur Respir J; 1989 Sep; 2(8):763-8. PubMed ID: 2680584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet activating factor: effects on bronchomotor tone and bronchial responsiveness in human beings.
    Chung KF; Cuss FM; Barnes PJ
    Allergy Proc; 1989; 10(5):333-7. PubMed ID: 2684754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of platelet activating factor-induced bronchoconstriction in humans.
    Smith LJ; Rubin AH; Patterson R
    Am Rev Respir Dis; 1988 May; 137(5):1015-9. PubMed ID: 3195800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAF-induced airway responses in sheep: effects of a PAF antagonist and nedocromil sodium.
    Soler M; Mansour E; Fernandez A; D'Brot J; Ahmed T; Abraham WM
    J Allergy Clin Immunol; 1990 Mar; 85(3):661-8. PubMed ID: 2155959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of inhaled lyso-platelet-activating factor on airway microvascular leakage in the guinea pig.
    Sakamoto T; Elwood W; Barnes PJ; Chung KF
    J Appl Physiol (1985); 1993 Mar; 74(3):1117-22. PubMed ID: 8482649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of platelet-activating factor on aerosol histamine responsiveness in awake sheep.
    Christman BW; Lefferts PL; Snapper JR
    Am Rev Respir Dis; 1987 Jun; 135(6):1267-70. PubMed ID: 3592402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of platelet-activating factor inhalation on nonspecific bronchial reactivity in man.
    Hopp RJ; Bewtra AK; Agrawal DK; Townley RG
    Chest; 1989 Nov; 96(5):1070-2. PubMed ID: 2680318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute bronchial and hematologic effects following inhalation of a single dose of PAF. Comparison between asthmatics and normal subjects.
    Louis R; Bury T; Corhay JL; Radermecker MF
    Chest; 1994 Oct; 106(4):1094-9. PubMed ID: 7924479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.